Intercure Ltd. Schedules Extraordinary General Meeting
Ticker: INCR · Form: 6-K · Filed: Sep 13, 2024 · CIK: 1857030
| Field | Detail |
|---|---|
| Company | Intercure Ltd. (INCR) |
| Form Type | 6-K |
| Filed Date | Sep 13, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Intercure Ltd. calling shareholder meeting Oct 28th - big decisions ahead.
AI Summary
Intercure Ltd. announced on September 13, 2024, that it will hold an Extraordinary General Meeting of Shareholders on October 28, 2024. The meeting will take place at 4:00 p.m. Israel time at the company's offices.
Why It Matters
This meeting is a crucial step for shareholders to vote on important company matters, potentially impacting the future direction and governance of Intercure Ltd.
Risk Assessment
Risk Level: low — The filing is a routine announcement of a shareholder meeting, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Intercure Ltd. (company) — Registrant
- September 13, 2024 (date) — Announcement Date
- October 28, 2024 (date) — Meeting Date
- 4:00 p.m. (Israel time) (time) — Meeting Time
FAQ
What is the purpose of the Extraordinary General Meeting of Shareholders?
The filing does not specify the exact agenda items for the Extraordinary General Meeting of Shareholders, but such meetings are typically held to vote on significant corporate matters.
Where will the Extraordinary General Meeting of Shareholders be held?
The meeting will be held at the offices of Intercure Ltd.
What is the filing number for this report?
The accession number for this filing is 0001493152-24-036118.
What is Intercure Ltd.'s standard industrial classification?
Intercure Ltd.'s standard industrial classification is Pharmaceutical Preparations [2834].
Does Intercure Ltd. file annual reports under Form 20-F or Form 40-F?
Intercure Ltd. indicates that it files annual reports under Form 20-F.
Filing Stats: 363 words · 1 min read · ~1 pages · Grade level 10.8 · Accepted 2024-09-13 08:30:30
Filing Documents
- form6-k.htm (6-K) — 21KB
- ex99-1.htm (EX-99.1) — 400KB
- ex99-2.htm (EX-99.2) — 47KB
- ex99-1_001.jpg (GRAPHIC) — 22KB
- 0001493152-24-036118.txt ( ) — 500KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INTERCURE LTD. Date: September 13, 2024 /s/ Amos Cohen Amos Cohen Chief Financial Officer